1321 related articles for article (PubMed ID: 28922704)
21. Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.
Hauser G; Awad T; Thorlund K; Štimac D; Mabrouk M; Gluud C
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005642. PubMed ID: 24585451
[TBL] [Abstract][Full Text] [Related]
22. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
[TBL] [Abstract][Full Text] [Related]
23. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.
Simonetti RG; Perricone G; Nikolova D; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004039. PubMed ID: 31251387
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
25. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic M; Nikolova D; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011564. PubMed ID: 34431511
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticosteroids for people with alcoholic hepatitis.
Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD001511. PubMed ID: 29096421
[TBL] [Abstract][Full Text] [Related]
28. Beta-blockers in patients without heart failure after myocardial infarction.
Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
[TBL] [Abstract][Full Text] [Related]
29. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
[TBL] [Abstract][Full Text] [Related]
30. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
[TBL] [Abstract][Full Text] [Related]
31. Acetyl-L-carnitine for patients with hepatic encephalopathy.
Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011451. PubMed ID: 30610762
[TBL] [Abstract][Full Text] [Related]
32. Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011647. PubMed ID: 28273330
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticosteroids for people with alcoholic hepatitis.
Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001511. PubMed ID: 30964545
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
Colli A; Fraquelli M; Prati D; Casazza G
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013532. PubMed ID: 37278488
[TBL] [Abstract][Full Text] [Related]
37. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
38. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
[TBL] [Abstract][Full Text] [Related]
40. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
Cochrane Database Syst Rev; 2012 Sep; (9):CD008516. PubMed ID: 22972122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]